Le Lézard
Classified in: Health
Subject: PER

'Change maker and champion': Louise Bradley announces plans to retire as head of the Mental Health Commission of Canada


Statement
From Mental Health Commission of Canada

OTTAWA, ON, Sept. 28, 2020 /CNW/ - More than 12 years ago, Louise Bradley joined the Mental Health Commission of Canada (MHCC) as its chief operating officer. Two years later, she took over the helm as president and CEO ? and has been a steady hand at the wheel ever since. Today, it's my bittersweet task to announce that Louise has informed the board of directors that she'd like us to begin the careful search for her replacement. She intends to retire once the right candidate has been found and has successfully transitioned into the role.

On behalf of the board, leadership, and staff, I want to express my heartfelt gratitude for Louise's unflagging dedication to the MHCC and to raising the profile of mental health in Canada.

Louise is an extraordinary leader. She mounted a tireless battle against stigma, relentlessly advocated for increased mental health funding, and has left an indelible imprint as head of the MHCC. Building the organization to more than 100 strong, Louise's tenure includes milestones like the world's largest research demonstration project on effective housing for people who live with serious mental illness, and the development of a made-in-Canada workplace standard on psychological health and safety. The MHCC's current inroads include the Roots of Hope community-based suicide prevention program and the proliferation of Stepped Care 2.0, a tiered approach to care that includes e-mental health.

In Louise's words, "We've turned a corner. The need for investment in mental health is no longer in dispute. This next stretch of highway belongs to someone else. We have an excellent board. We have a new mandate and work plan. And our value and relevance as an organization has never been stronger. This is a natural leadership change point, and it will allow for someone with fresh ideas and new energy to shepherd the organization's next chapter."

The pandemic has underscored the need for increased mental health supports and services and has reinforced the MHCC's essential role in developing sound policy to underpin those investments.

While filling Louise's shoes will be no easy task, she emphasized, "The board shouldn't be looking to replace me. I've done my part, and I'm ready for the next adventure. Your task now is to find someone whose talents, skills, and experience are suited to the challenges that lie around the corner. But one thing will never change: I will always be the organization's biggest champion."

Chuck Bruce
Board Chair, Mental Health Commission of Canada

Stay Connected

Follow MHCC on Facebook 
Follow MHCC on Twitter 
Follow MHCC on LinkedIn 
Follow MHCC on Instagram 
Subscribe to MHCC on YouTube

SOURCE Mental Health Commission of Canada


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: